Presentation

On

Presented by:-
Shyam Karan Mahajan
MMM-A
Our Logo

Lupin flower after which
the group has been named.
Which nourishes the soil in which it grows.
Benefiting the environment in the process.

Mission Statement
Mission:

Lupins mission is to become a transnational pharmaceutical
company through the development and introduction of a wide
portfolio of branded and generic products in key products.

Vision:



Lupin Pharmaceuticals, Inc. is committed to bringing innovative
products for the healthcare professional to improve the health
and well being of individuals.

About Company
Lupin Pharmaceuticals, Inc. is the U.S. wholly owned
subsidiary of Lupin Limited.

Lupin is among the top five pharmaceutical company in
India.

Lupin is having its headquarters in Baltimore.

Vinita Gupta is President of Lupin Pharmaceuticals.

The company has a state-of-the-art R&D center in Pune.

Lupins plants are located at Mandideep, Aurangabad,
Tarapur, Ankleshwar and Goa, in India.

Products

Generics




Lupin Pharmaceuticals, Inc. entered the U.S. generic
pharmaceutical market in 2003 with the ANDA approval for
cefuroxime axetil. Since then we have received more than a
dozen FDA approvals.

Specialty



Lupin Pharmaceuticals, Inc. is very pleased to be able to
bring Suprax an important anti-infective product in
pediatric practice, back to the US market. Lupin
Pharmaceuticals, Inc. has an exclusive license in the US to
use the Suprax trademark.

Products

API



Lupin is recognized as a leading manufacturer of
cephalosporin APIs, with FDA approval to manufacture
complex oral and injectable cephalosporin's.
a

Revenues & Profits

For the financial year ended March 2006
Revenues
Rs.16, 610 million (US$ 375 million)

Profit after Tax
Rs.1, 827 million (US$ 41 million)
Contact Address
Lupin Pharmaceuticals, Inc.
Harborplace Tower
111 S. Calvert Street,
21st Floor
Baltimore, MD 21202

Phone:
(800) 466-1450 or (410) 576-2000

Fax:
(410) 576-2221

Toll-free no:
1-800-399-2561.

Website:
www.lupinpharmaceuticals.com




THANKS.